Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Hebert

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
JAMA|March 12, 1982
Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatmentS A Carstens, L A Hebert, J C Garancis, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1994
Rate of antigen entry into the circulation in experimental versus naturally occurring immune complex glomerulonephritisL A Hebert, D J Birmingham, X P Shen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1995
Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosusL A Hebert, J J Dillon, D F Middendorf, et al.
American Journal of Nephrology|March 23, 1999
Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathyL A Hebert, M E Falkenhain, N S Nahman, et al.
Kidney International|August 1, 1996
Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patientsD J Birmingham, X P Shen, J A Hartman, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1994
Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35)L A Hebert, D J Birmingham, J J Dillon, et al.
Kidney International|December 1, 1991
Measurement of SC5b-9 in urine in patients with the nephrotic syndromeJ L Ogrodowski, L A Hebert, D Sedmak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primatesF G Cosio, X P Shen, D J Birmingham, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1981
Method for detecting a progressive renal disorder superimposed on a preexisting progressive renal disorderP Mavrelis, L A Hebert, J Lemann, et al.
Nephron|January 1, 1985
Adverse effect of exercise on immune complex-mediated glomerulonephritisJ B Cornacoff, L A Hebert, H M Sharma, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
JAMA|March 12, 1982
Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatmentS A Carstens, L A Hebert, J C Garancis, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1994
Rate of antigen entry into the circulation in experimental versus naturally occurring immune complex glomerulonephritisL A Hebert, D J Birmingham, X P Shen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1995
Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosusL A Hebert, J J Dillon, D F Middendorf, et al.
American Journal of Nephrology|March 23, 1999
Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathyL A Hebert, M E Falkenhain, N S Nahman, et al.
Kidney International|August 1, 1996
Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patientsD J Birmingham, X P Shen, J A Hartman, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1994
Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35)L A Hebert, D J Birmingham, J J Dillon, et al.
Kidney International|December 1, 1991
Measurement of SC5b-9 in urine in patients with the nephrotic syndromeJ L Ogrodowski, L A Hebert, D Sedmak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primatesF G Cosio, X P Shen, D J Birmingham, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1981
Method for detecting a progressive renal disorder superimposed on a preexisting progressive renal disorderP Mavrelis, L A Hebert, J Lemann, et al.
Nephron|January 1, 1985
Adverse effect of exercise on immune complex-mediated glomerulonephritisJ B Cornacoff, L A Hebert, H M Sharma, et al.
Pageof 10